Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Return on Sales (2020 - 2025)

Historic Return on Sales for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to 0.96%.

  • SOPHiA GENETICS's Return on Sales rose 1800.0% to 0.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.96% for FY2024, which is 3100.0% up from last year.
  • Latest data reveals that SOPHiA GENETICS reported Return on Sales of 0.96% as of Q3 2025, which was up 1800.0% from 1.14% recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Return on Sales registered a high of 0.81% during Q3 2023, and its lowest value of 2.3% during Q1 2022.
  • For the 5-year period, SOPHiA GENETICS's Return on Sales averaged around 1.4%, with its median value being 1.37% (2021).
  • Per our database at Business Quant, SOPHiA GENETICS's Return on Sales soared by 2000000000bps in 2021 and then crashed by -9300bps in 2022.
  • SOPHiA GENETICS's Return on Sales (Quarter) stood at 2.05% in 2021, then skyrocketed by 47bps to 1.08% in 2022, then crashed by -30bps to 1.41% in 2023, then skyrocketed by 39bps to 0.85% in 2024, then dropped by -13bps to 0.96% in 2025.
  • Its Return on Sales stands at 0.96% for Q3 2025, versus 1.14% for Q2 2025 and 0.92% for Q1 2025.